Form 4 • Statement of Changes in Beneficial Ownership
Type
Sell
Net shares
+20,893
% of shares
173.52%
Amount (USD)
$21,988
Insider confidence score
91.3 out of 100
Positive
Negative
Security
Common Stock
Action
Grant
Date
2026-03-03
Code
A
Net shares
+16,311.0
Acquired/Disposed
Acquired
Shares Owned Before
12,041.0
Shares Owned After
28,352.0
Security
Common Stock
Action
Grant
Date
2026-03-03
Code
A
Net shares
+5,408.0
Acquired/Disposed
Acquired
Shares Owned Before
28,352.0
Shares Owned After
33,760.0
Security
Common Stock
Action
Tax_withhold
Date
2026-03-04
Code
F
Net shares
-826.0
Price per Share
$26.62
Amount (USD)
$21,988.12
Acquired/Disposed
Disposed
Shares Owned Before
33,760.0
Shares Owned After
32,934.0
Security
Stock Appreciation Rights
Action
Grant
Date
2026-03-03
Code
A
Net shares
+22,638.0
Acquired/Disposed
Acquired
Shares Owned Before
0.0
Shares Owned After
22,638.0
1. The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
2. The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
3. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.